Section: ANTI-CANCER
DRUG DESIGN AND DISCOVERY
Organizing Secretary: Michael J. Waring
Department of Pharmacology
University of Cambridge, UK
|
INVITED LECTURES
|
The Long March Towards Effective and Selective
Drug Treatment of Cancer
Michael J. Waring
Department of Pharmacology, University of Cambridge,
UK
|
| Dugging the Cancer Genome: Molecular Therapeutics
and Biomarkers for Personalized Cancer Medicine
Paul Workman
Director, Cancer Research UK, Center for Cancer
Therapeutics, The Institute of Cancer Research, Haddow
Laboratories, UK
|
| Histone Deacetylase Inhibitors: Mechanisms
of Action and Clinical Development
Paul A. Marks
President Emeritus, Memorial Sloan-Kettering Cancer
Center
|
| Supramolecular Anticancer Drugs: From Design
to Reality
Kurt E. Geckeler
Department of Materials Science and Engineering,
Gwangju Institute of Science and Technology, South Korea
|
|
